Therapeuting compositions comprising an RNAi agent and a neurotrophic factor and methods of use thereof
US8173614B2 · kind B2 · utility
5Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2009 |
| Grant date | May 8, 2012 |
| Priority date | — |
| Expiry date | Nov 26, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel combination therapies for treating Huntington's disease which comprise a) BDNF or suitable fragments thereof and b) agents capable of causing inhibition of a gene responsible for the neurodegenerative disease. The invention provides nucleic acid sequences, methods, and systems suitable for applications of these combination therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.